Annals of Coloproctology

Display

Sort by :

Original Article

Colorectal cancer

Predictors of lateral lymph node metastasis and prognostic factors in patients with low rectal cancer who underwent lateral lymph node dissection without preoperative treatment: Riki Ohno, Haruka Oi, Soichiro Natsume, Kazuki Kawasaki, Yuichiro Yoshioka, Nao Kakizawa, Junko Kishikawa, Toshiya Nagasaki; Ann Coloproctol. 2025;41(6):545-553. Published online December 29, 2025; DOI: https://doi.org/10.3393/ac.2025.00675.0096

727 View
41 Download
1 Web of Science
1 Citations

Purpose
This study aimed to identify predictors of lateral lymph node metastasis (LLNM) and assess prognostic factors in patients with locally advanced low rectal cancer (LALRC), with the goal of informing optimal treatment strategies for LALRC.
Methods
We retrospectively analyzed clinicopathological data from patients with LALRC who underwent lateral lymph node dissection without preoperative treatment between 2014 and 2023. The radiological criterion for LLNM was a short-axis diameter of ≥6 mm on magnetic resonance imaging (MRI).
Results
Of 163 patients, 27 (16.6%) had pathological LLNM (pLLNM). Among 130 patients preoperatively classified as LLNM-negative, 5 (3.8%) were found to have pLLNM. Univariate and multivariate analyses showed that meeting the radiological LLNM criterion independently predicted pLLNM (odds ratio, 53.000; P<0.001). The accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of this criterion were 90.2%, 81.5%, 91.9%, 66.7%, and 96.2%, respectively. In multivariate analyses, pLLNM was an independent risk factor for 3‑year relapse‑free survival. MRI‑detected extramural vascular invasion (mrEMVI) was independently associated with 3‑year relapse‑free survival, local recurrence‑free survival, and distant recurrence‑free survival.
Conclusion
These radiological criteria may help clinicians develop personalized treatment plans for patients with LALRC. The high negative predictive value and specificity of LLNM assessment can assist in avoiding overtreatment in appropriate patients. Further evaluation is needed to define optimal management for mrEMVI‑positive cases.

Citations

Citations to this article as recorded by

Clinical implications of radiologic criteria and prognostic factors for lateral lymph node metastasis in low rectal cancer
Gyung Mo Son
Annals of Coloproctology.2025; 41(6): 489. CrossRef

Review

Clinical Implications of Lymph Node Metastasis in Colorectal Cancer: Current Status and Future Perspectives: Hye Jin Kim, Gyu–Seog Choi; Ann Coloproctol. 2019;35(3):109-117. Published online June 30, 2019; DOI: https://doi.org/10.3393/ac.2019.06.12

24,802 View
384 Download
66 Web of Science
66 Citations

Abstract PDF

Lymph node metastasis is regarded as an indubitable prognostic factor for predicting disease recurrence and survival in patients with colorectal cancer. Lymph node status based on examination of a resected specimen is a key element of the current staging system and is also a crucial factor to determine use of adjuvant chemotherapy after surgical resection. However, the current tumor-node-metastasis (TNM) staging system only incorporates the number of metastatic lymph nodes in the N category. Numerous attempts have been made to supplement this simplified N staging including lymph node ratio, distribution of metastatic lymph nodes, tumor deposits, or extracapsular invasion. In addition, several attempts have been made to identify more specific prognostic factors in resected colorectal specimens than lymph node status. In this review, we will discuss controversies in lymph node staging and factors that may influence survival beyond lymph node status.

Citations

Citations to this article as recorded by

Dual RPA-CRISPR/Cas13a parallel detection of serum cell-free RNA and internal SDK1 m7G for diagnosis of early colorectal cancer metastasis
Chenxi Wu, Jie Zhang, Huirong Wu, Min Jiang, Jiaqi Cui, Lin Huang, Xiaofeng Zeng, Yun Lan, Haoyu Xiao, Tiantian Zhou, Jianfeng Zhang, Weifeng Ding
Sensors and Actuators B: Chemical.2026; 450: 139236. CrossRef
Association of the Number of Negative Lymph Nodes Removed with Overall Survival and Recurrence Rates in Patients with Colorectal Cancer Following Surgery: A Multicenter Retrospective Cohort Study
Mansour Bahardoust, Fatemeh Naseri Rad, Mohammadsadra Shamohammadi, Roumina Behegam, Meisam Haghmoradi, Babak Godarzi, Adnan Tizmaghz
Journal of Gastrointestinal Cancer.2026;[Epub] CrossRef
Integrative Multiscale Analysis Reveals EFNA1‐Driven Immune Remodeling Promotes Colorectal Cancer Lymph Node Metastasis
Wu Ning, Nan Qiao, Lei Zhou, Zongze Li, Lin Zhang, Xin Song, Shaoqiu Chen
Human Mutation.2026;[Epub] CrossRef
Predicting lymph node metastasis in colorectal cancer using case-level multiple instance learning
Ling-Feng Zou, Xuan-Bing Wang, Jing-Wen Li, Xin Ouyang, Yi-Ying Luo, Yan Luo, Cheng-Long Wang
World Journal of Gastroenterology.2026;[Epub] CrossRef
Role of Adjuvant Chemotherapy After Surgical Resection of Paraaortic Lymph Node Metastasis from Colorectal Cancer—A Multicenter Retrospective Study
Hiroaki Nozawa, Sono Ito, Kazuhito Sasaki, Koji Murono, Shigenobu Emoto, Yuichiro Yokoyama, Shinichi Yamauchi, Yusuke Kinugasa, Yoichi Ajioka, Soichiro Ishihara
Annals of Surgical Oncology.2025; 32(4): 2282. CrossRef
Lighthouses illuminating tumor metastasis: The application of fluorescent probes in the localization and imaging metastatic lymph nodes across various tumors
Qi Dang, Linhao Zhang, Huipeng Ma, Xiaoshan Sun, Anguo Ren, Jiuyang Chen, Xiaohua Huang, Boyu Zhang, Wen Sun
Biomaterials.2025; 316: 123020. CrossRef
Lymph node yield does not affect the cancer-specific survival of patients with T1 colorectal cancer: a population-based retrospective study of the U.S. database and a Chinese registry
Jiyun Li, Ruoxi Tian, Fei Huang, Pu Cheng, Fuqiang Zhao, Zhixun Zhao, Qian Liu, Zhaoxu Zheng
International Journal of Colorectal Disease.2025;[Epub] CrossRef
Long‐Term Outcomes of Sigmoid, Rectosigmoid, and Rectal Cancers: A Matched Analysis
Cigdem Benlice, Atilla Halil Elhan, Emre Gorgun, Mehmet Ayhan Kuzu
World Journal of Surgery.2025; 49(4): 819. CrossRef
The Value of Spectroscopic CT for Lymph Node Metastasis in Rectal Cancer
冬冬穆
Journal of Clinical Personalized Medicine.2025; 04(01): 501. CrossRef
A novel pN stage prediction model for resectable rectal adenocarcinoma based on preoperative MRI features and multiregional apparent diffusion coefficients
Hui Luo, Yue-qin Gou, Yue-su Wang, Hui-lin Qin, Hai-ying Zhou, Xiao-ming Zhang, Tian-wu Chen
European Radiology.2025; 35(9): 5760. CrossRef
Indocyanine Green Near-Infrared Fluorescence-Guided Sentinel Lymph Node Biopsy in Colon Cancer
Vlad Fagarasan, Vasile V. Bintintan, Radu I. Seicean, Giorgiana Fagarasan, David Andras, Emil Botan, Gabriel Samasca, George C. Dindelegan, Calin I. Cainap
Biomedicines.2025; 13(4): 902. CrossRef
Performance and Prognostic Relevance of Lymph Node Assessment by One-Step Nucleic Acid Amplification Assay in Rectal Cancer: A Multicenter Study
Qing Liu, Sandra Lopez-Prades, Karmele Saez de Gordoa, Maite Rodrigo-Calvo, Mireia Garcia, Juan Ruiz Martin, Angel Romo, Ignacio Pinilla, Jordi Tarragona, Begoña Otero Alen, Jordi Camps, Ivan Archilla, Miriam Cuatrecasas
Cancers.2025; 17(13): 2141. CrossRef
Prognostic value of metastatic lymph node ratio and its effect on disease-free survival in colon cancer
Orhan Aslan, Ramazan Topcu, İsmail Sezikli, Mahmut A. Yüksek, Aşkın K. Perçem, Furkan Uğur
Frontiers in Oncology.2025;[Epub] CrossRef
B7-H3: a consistent marker in metastatic colorectal cancer with potential for targeted treatment
Julia M. Ott, Verena Gassenmaier, Michael Bitzer, Christian M. Schürch, Jonas S. Heitmann, Ilona Hagelstein
Pathology and Oncology Research.2025;[Epub] CrossRef
The application of random forest-based models in prognostication of gastrointestinal tract malignancies: a systematic review
Zhina Mohamadi, Ahmad Shafizadeh, Yasaman Aliyan, Seyedeh Fatemeh Shayesteh, Parsa Goudarzi, Alireza Khodabandeh, Amirali Vaghari, Helma Ashrafi, Omid Bahrami, Armin ZarinKhat, Yalda Khodabandeh, Kimia Pouyan
Frontiers in Artificial Intelligence.2025;[Epub] CrossRef
Mutation profiling of KRAS and BRAF in primary tumours and circulating tumour cells of colorectal cancer patients using PNA-LNA molecular switch
Md Sajedul Islam, Eliza Ranjit, Sharmin Aktar, Neda Moetamedirad, Cu Tai Lu, Muhammad J.A. Shiddiky, Vinod Gopalan, Alfred K. Lam
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(7): 167982. CrossRef
Utilizing tumor deposit count as a stratification criterion in revising TNM staging system for patients with colorectal cancer: a nomogram review study
Lifei Zhang, Yunna Ma, Jiantao Dong, Jianhui Cai
Frontiers in Oncology.2025;[Epub] CrossRef
An Uncharted Path of Metastasis: A Case Report of Sigmoid Colon Cancer with Synchronous Vaginal and Urethral Spread
John Fernando Montenegro, Giovanna Patricia Rivas Tafur, Miguel Diaz, Diego Fernando Alzate, María Camila Faria, Daniel Florez, Richard Andrés Acuña, Cesar Eduardo, Yamil Liscano
Diseases.2025; 13(8): 251. CrossRef
Construction of a risk prediction model for early postoperative recurrence in stage II/III colorectal cancer
Feng-Chun Xiong, Ming-Peng Luo, Shan-Ming Ruan
World Journal of Gastrointestinal Oncology.2025;[Epub] CrossRef
Peritoneal Lavage Cytology Predicts Peritoneal Metastasis and is Associated with Poor Prognosis in Patients with Stage II–III Colorectal Cancer
Dewei Kong, Yingjie Li, Shenyi Yin, Yunfei Tan, Boyang Qu, Lei Huang, Jianzhong Jeff Xi, Aiwen Wu
Annals of Surgical Oncology.2025; 32(13): 9712. CrossRef
Insights from the Muk and Maseb Radiotherapy Centre in Kinshasa: A Study of 43 Cases of Rectal Cancer
Abou Dao, Emmanuel Franck Elame, Mahomed Yessoufou, Ismael Coulibaly, Kanta Ka, Vandrome Nakundi, Ruth Rosine Mapenya Mekah, Anne-Marthe Maison Mayeh, Guilaine Mopoh, Nicolas A. A. Minoungou, Franck Mukeng, Mah-Soune Apithy, Babaka Donatien Batalansi, Sta
Journal of Cancer Therapy.2025; 16(12): 472. CrossRef
Machine learning-based survival prediction in colorectal cancer combining clinical and biological features
Lucas M. Vieira, Natasha A.N. Jorge, João B. Sousa, João C. Setubal, Peter F. Stadler, Maria E.M.T. Walter
Oncotarget.2025; 16(1): 834. CrossRef
TRAIL‐conjugated liposomes that bind natural killer cells to induce colorectal cancer cell apoptosis
Joshua D. Greenlee, Zhenjiang Zhang, Tejas Subramanian, Kevin Liu, Michael R. King
Journal of Biomedical Materials Research Part A.2024; 112(1): 110. CrossRef
Lymph Node Ratio as a Predictor of Survival for Colon Cancer: A Systematic Review and Meta-Analysis
Simarpreet Ichhpuniani, Tyler McKechnie, Jay Lee, Jeremy Biro, Yung Lee, Lily Park, Aristithes Doumouras, Dennis Hong, Cagla Eskicioglu
The American Surgeon™.2024; 90(4): 840. CrossRef
Acetone compression improves lymph node yield and metastasis detection in colorectal cancer
Christina Schnoz, Katrin Schmid, Guacimara Ortega Sanchez, Sabina Schacher-Kaufmann, Michel Adamina, Georgios Peros, Dieter Erdin, Peter Karl Bode
Clinical & Experimental Metastasis.2024; 41(1): 45. CrossRef
Computational methods for metastasis detection in lymph nodes and characterization of the metastasis-free lymph node microarchitecture: A systematic-narrative hybrid review
Elzbieta Budginaite, Derek R. Magee, Maximilian Kloft, Henry C. Woodruff, Heike I. Grabsch
Journal of Pathology Informatics.2024; 15: 100367. CrossRef
Sequential Lateral Lymphatic Metastasis Shows Similar Oncologic Outcomes to Upward Spread in Advanced Rectal Cancer After Preoperative Chemoradiotherapy
Hye Jin Kim, Gyu-Seog Choi, Seung Hyun Cho, Min Kyu Kang, Jun Seok Park, Soo Yeun Park, Byung Woog Kang, Jong Gwang Kim
Diseases of the Colon & Rectum.2024; 67(3): 359. CrossRef
The Evolving Role of Artificial Intelligence in Gastrointestinal Histopathology: An Update
D. Chamil Codipilly, Shahriar Faghani, Catherine Hagan, Jason Lewis, Bradley J. Erickson, Prasad G. Iyer
Clinical Gastroenterology and Hepatology.2024; 22(6): 1170. CrossRef
INFLUENCE OF NEOADJUVANT THERAPY ON THE RATIO OF LYMPH NODES
Laura CREDIDIO, Carlos Augusto Real MARTINEZ, Daniéla Oliveira MAGRO, Rita Barbosa de CARVALHO, Maria de Lourdes Setsuko AYRIZONO, Cláudio Saddy Rodrigues COY
Arquivos de Gastroenterologia.2024;[Epub] CrossRef
National screening for colorectal cancer is associated with stage shift to earlier diagnosis
Mina Sarofim, Amir Ashrafizadeh, Anthony J. Gill, Keshani de Silva, Justin Evans, Stephen Clarke, Nick Pavlakis, Ian Norton, Alexander Engel
ANZ Journal of Surgery.2024; 94(7-8): 1279. CrossRef
Competing‐risks model for predicting the prognosis of patients with regressive melanoma based on the SEER database
Chaodi Huang, Liying Huang, Jianguo Huang, Xinkai Zheng, Congjun Jiang, Kong Ching Tom, U. Tim Wu, WenHsien Ethan Huang, Yunfei Gao, Fangmin Situ, Hai Yu, Liehua Deng, Jun Lyu
Malignancy Spectrum.2024; 1(2): 123. CrossRef
The Relationship between Tumor Budding and Tumor Deposits in Patients with Stage III Colorectal Carcinoma
Zdenko Bilić, Mario Zovak, Goran Glavčić, Dubravka Mužina, Amir Ibukić, Andro Košec, Davor Tomas, Alma Demirović
Journal of Clinical Medicine.2024; 13(9): 2583. CrossRef
Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts
Julien Taieb, Debora Basile, Jenny Seligmann, Guillem Argiles, Thierry André, Claire Gallois, Richard M. Goldberg, Greg Yothers, Alberto Sobrero, Jeffrey A. Meyerhardt, John Souglakos, Roberto Labianca, Tim Iveson, David N. Church, Dirk Arnold, Jeanne Tie
European Journal of Cancer.2024; 206: 114118. CrossRef
GLI1 and PTTG1 expression in colorectal carcinoma patients undergoing radical surgery and their correlation with lymph node metastasis
Feng Cao, Yang-Yan Chen, Hong-Cheng Wang
World Journal of Gastrointestinal Surgery.2024; 16(5): 1328. CrossRef
Application of radiomics for preoperative prediction of lymph node metastasis in colorectal cancer: a systematic review and meta-analysis
Elahe Abbaspour, Sahand Karimzadhagh, Abbas Monsef, Farahnaz Joukar, Fariborz Mansour-Ghanaei, Soheil Hassanipour
International Journal of Surgery.2024; 110(6): 3795. CrossRef
A pathologist–AI collaboration framework for enhancing diagnostic accuracies and efficiencies
Zhi Huang, Eric Yang, Jeanne Shen, Dita Gratzinger, Frederick Eyerer, Brooke Liang, Jeffrey Nirschl, David Bingham, Alex M. Dussaq, Christian Kunder, Rebecca Rojansky, Aubre Gilbert, Alexandra L. Chang-Graham, Brooke E. Howitt, Ying Liu, Emily E. Ryan, Tr
Nature Biomedical Engineering.2024; 9(4): 455. CrossRef
OPTIMIZATION OF THE DIAGNOSIS OF LYMPH NODE METASTASIS IN PATIENTS WITH COLORECTAL CANCER USING RADIOLOGICAL IMAGING METHODS
S.V. Maliborska, V.V. Holotiuk
Art of Medicine.2024; : 63. CrossRef
Low muscle mass-to-fat ratio is an independent factor that predicts worse overall survival and complications in patients with colon cancer: a retrospective single-center cohort study
Jiabao Tang, Jingwen Xu, Xiaohua Li, Chun Cao
Annals of Surgical Treatment and Research.2024; 107(2): 68. CrossRef
Biomarkers of lymph node metastasis in colorectal cancer: update
Xiao Zhu, Shui-quan Lin, Jun Xie, Li-hui Wang, Li-juan Zhang, Ling-ling Xu, Jian-guang Xu, Yang-bo Lv
Frontiers in Oncology.2024;[Epub] CrossRef
SURGICAL TREATMENT OF RECTAL CANCER WITH PRESERVATION OF THE LEFT COLIC ARTERY AND ICG NAVIGATION
S.V. Maliborska
Art of Medicine.2024; : 86. CrossRef
Assessing the clinical utility of tumor invasion proportion of lymph nodes for enhanced risk stratification in N1 colorectal cancer
Ru-Jie Chen
American Journal of Cancer Research.2024; 14(12): 5826. CrossRef
Survival outcomes after synchronous para‐aortic lymph node metastasis in colorectal cancer: A systematic review
Conor Aylward, Jawed Noori, Jack Tyrrell, Niall O'sullivan, Dara O. Kavanagh, John O. Larkin, Brian J. Mehigan, Paul H. McCormick, Michael E. Kelly
Journal of Surgical Oncology.2023; 127(4): 645. CrossRef
National assessment of lymph node status indicators & predictors in pediatric head and neck rhabdomyosarcomas in the US
David J. Fei-Zhang, Asher C. Park, Joseph M. Berry, Rebecca S. Arch, Daniel C. Chelius, Anthony M. Sheyn, Jeffrey C. Rastatter
International Journal of Pediatric Otorhinolaryngology.2023; 164: 111419. CrossRef
Increased Kremen2 predicts worse prognosis in colon cancer
Junxian Long, Fengyun Cong, Yousheng Wei, Jungang Liu, Weizhong Tang
Pathology and Oncology Research.2023;[Epub] CrossRef
Predictors and survival outcomes of having less than 12 harvested lymph nodes in proctectomy for rectal cancer
Sameh Hany Emile, Nir Horesh, Zoe Garoufalia, Rachel Gefen, Peige Zhou, Steven D. Wexner
International Journal of Colorectal Disease.2023;[Epub] CrossRef
Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions
Haoran Ji, Chuang Hu, Xuhui Yang, Yuanhao Liu, Guangyu Ji, Shengfang Ge, Xiansong Wang, Mingsong Wang
Signal Transduction and Targeted Therapy.2023;[Epub] CrossRef
The Role of Nonmetastatic Lymph Nodes in the Survival of Colorectal Cancer: A Systematic Review
Alexander J. Pennings, Brecht A. van der Velden, Maximilian Kloft, Loes F. S. Kooreman, Jos M. P. Kleijnen, Stephanie O. Breukink, Geerard L. Beets, Heike I. Grabsch, Jarno Melenhorst
Annals of Surgery Open.2023; 4(4): e336. CrossRef
Multicenter study of prognostic factors in paraaortic lymph node dissection for metastatic colorectal cancer
Jun Woo Bong, Sanghee Kang, Pyoungjae Park
Annals of Surgical Treatment and Research.2023; 105(5): 271. CrossRef
Long-Term Outcomes of Surgical Resection of Pathologically Confirmed Isolated Para-Aortic Lymph Node Metastases in Colorectal Cancer: A Systematic Review
Maurizio Zizzo, Maria Pia Federica Dorma, Magda Zanelli, Francesca Sanguedolce, Maria Chiara Bassi, Andrea Palicelli, Stefano Ascani, Alessandro Giunta
Cancers.2022; 14(3): 661. CrossRef
Risk factors for long-term survival in patients with ypN+ M0 rectal cancer after radical anterior resection
Marcin Zeman, Władysław Skałba, Piotr Szymański, Grzegorz Hadasik, Dmytro Żaworonkow, Dominik A. Walczak, Agnieszka Czarniecka
BMC Gastroenterology.2022;[Epub] CrossRef
Watch and wait strategies for rectal cancer: A systematic review
In Ja Park
Precision and Future Medicine.2022; 6(2): 91. CrossRef
An unusual case of right-sided colon cancer with isolated lateral pelvic side wall lymph node metastases
Rishaan Pawaskar, James Wei Tatt Toh
Laparoscopic, Endoscopic and Robotic Surgery.2022; 5(3): 121. CrossRef
High-resolution MRI-based radiomics analysis to predict lymph node metastasis and tumor deposits respectively in rectal cancer
Yan-song Yang, Feng Feng, Yong-juan Qiu, Gui-hua Zheng, Ya-qiong Ge, Yue-tao Wang
Abdominal Radiology.2021; 46(3): 873. CrossRef
Extricating the Association Between the Prognostic Factors of Colorectal Cancer
Younis Mohd, Balamuralikrishnan Balasubramanian, Arun Meyyazhagan, Haripriya Kuchi Bhotla, Suresh Kumar Shanmugam, Mithun Kumar Ramesh Kumar, Manikantan Pappusamy, Karthick Kumar Alagamuthu, Sasikala Keshavarao, Vijaya Anand Arumugam
Journal of Gastrointestinal Cancer.2021; 52(3): 1022. CrossRef
Retrospective survival analysis of stage II–III rectal cancer: tumour regression grade, grading and lymphovascular invasion are the only predictors
Andrea Morini, Alfredo Annicchiarico, Andrea Romboli, Matteo Ricco', Pellegrino Crafa, Filippo Montali, Paolo Dell'Abate, Renato Costi
ANZ Journal of Surgery.2021;[Epub] CrossRef
Competitive Risk Analysis of Prognosis in Patients With Cecum Cancer: A Population-Based Study
Wentao Wu, Jin Yang, Daning Li, Qiao Huang, Fanfan Zhao, Xiaojie Feng, Hong Yan, Jun Lyu
Cancer Control.2021;[Epub] CrossRef
Increased Expression of VANGL1 is Predictive of Lymph Node Metastasis in Colorectal Cancer: Results from a 20-Gene Expression Signature
Noshad Peyravian, Stefania Nobili, Zahra Pezeshkian, Meysam Olfatifar, Afshin Moradi, Kaveh Baghaei, Fakhrosadat Anaraki, Kimia Nazari, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Enrico Mini, Ehsan Nazemalhosseini Mojarad
Journal of Personalized Medicine.2021; 11(2): 126. CrossRef
Management of indeterminate hepatic nodules and evaluation of factors predicting their malignant potential in patients with colorectal cancer
Mizelle D’Silva, Jai Young Cho, Ho-Seong Han, Taupyk Yerlan, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonhwan Kim
Scientific Reports.2021;[Epub] CrossRef
Optimal Postoperative Surveillance Strategies for Colorectal Cancer: A Retrospective Observational Study
Min-Young Park, In-Ja Park, Hyo-Seon Ryu, Jay Jung, Min-Sung Kim, Seok-Byung Lim, Chang-Sik Yu, Jin-Cheon Kim
Cancers.2021; 13(14): 3502. CrossRef
Outcomes of Level of Ligation of Inferior Mesenteric Artery in Colorectal Cancer: a Systematic Review and Meta-Analysis
Pavan Kumar Jonnada, Monish Karunakaran, Dayakar Rao
Future Oncology.2021; 17(27): 3645. CrossRef
Gastrointestinal cancer classification and prognostication from histology using deep learning: Systematic review
Sara Kuntz, Eva Krieghoff-Henning, Jakob N. Kather, Tanja Jutzi, Julia Höhn, Lennard Kiehl, Achim Hekler, Elizabeth Alwers, Christof von Kalle, Stefan Fröhling, Jochen S. Utikal, Hermann Brenner, Michael Hoffmeister, Titus J. Brinker
European Journal of Cancer.2021; 155: 200. CrossRef
One-Step Nucleic Acid Amplification (OSNA) of Sentinel Lymph Node in Early-Stage Endometrial Cancer: Spanish Multicenter Study (ENDO-OSNA)
María Diestro, Alberto Berjón, Ignacio Zapardiel, Laura Yébenes, Irune Ruiz, Arantza Lekuona, Marta Rezola, Ibon Jaunarena, Jaime Siegrist, Margarita Sánchez-Pastor, María Cuadra, Amaia Sagasta, Isabel Guerra, Luis Lete, Fernando Roldán, Carlo Marta, Marí
Cancers.2021; 13(17): 4465. CrossRef
Deep learning can predict lymph node status directly from histology in colorectal cancer
Lennard Kiehl, Sara Kuntz, Julia Höhn, Tanja Jutzi, Eva Krieghoff-Henning, Jakob N. Kather, Tim Holland-Letz, Annette Kopp-Schneider, Jenny Chang-Claude, Alexander Brobeil, Christof von Kalle, Stefan Fröhling, Elizabeth Alwers, Hermann Brenner, Michael Ho
European Journal of Cancer.2021; 157: 464. CrossRef
Pathological Features and Prognostication in Colorectal Cancer
Kabytto Chen, Geoffrey Collins, Henry Wang, James Wei Tatt Toh
Current Oncology.2021; 28(6): 5356. CrossRef
Distant Metastasis in Colorectal Cancer Patients—Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review
Stanislav Filip, Veronika Vymetalkova, Jiri Petera, Ludmila Vodickova, Ondrej Kubecek, Stanislav John, Filip Cecka, Marketa Krupova, Monika Manethova, Klara Cervena, Pavel Vodicka
International Journal of Molecular Sciences.2020; 21(15): 5255. CrossRef
Small Molecules for Multi-Wavelength Near-Infrared Fluorescent Mapping of Regional and Sentinel Lymph Nodes in Colorectal Cancer Staging
Victor M. Baart, Marion M. Deken, Mark W. Bordo, Shadhvi S. Bhairosingh, Daniela C. F. Salvatori, Hoon Hyun, Maged Henary, Hak Soo Choi, Cornelis F. M. Sier, Peter J. K. Kuppen, Anton G. T. Terwisscha van Scheltinga, Taryn L. March, Adrianus R. P. M. Vale
Frontiers in Oncology.2020;[Epub] CrossRef

Original Articles

Reliability of ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Nodal Staging of Colorectal Cancer Patients: Hee Jung Yi, Kyung Sook Hong, Nara Moon, Soon Sup Chung, Ryung-Ah Lee, Kwang Ho Kim; Ann Coloproctol. 2014;30(6):259-265. Published online December 31, 2014; DOI: https://doi.org/10.3393/ac.2014.30.6.259

5,533 View
41 Download
8 Web of Science
7 Citations

Abstract PDF

Purpose

Lymph-node metastasis is considered as critical prognostic factor in colorectal cancer. A preoperative evaluation of lymph-node metastasis can also help to determine the range of distant lymph node dissection. However, the reliability of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in the detection of lymph-node metastasis is not fully known.

Methods

The medical records of 433 patients diagnosed with colorectal cancer were reviewed retrospectively. FDG-PET/CT and CT were performed on all patients. Lymph nodes were classified into regional and distant lymph nodes according to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 7th edition.

Results

The patients included 231 males (53.3%) and 202 females (46.7%), with a mean age of 64.7 ± 19.0 years. For regional lymph nodes, the sensitivity of FDG-PET/CT was lower than that of CT (57.1% vs. 73.5%, P < 0.001). For distant lymph nodes, the sensitivity of FDG-PET/CT was higher than that of CT (64.7% vs. 52.9%, P = 0.012). The sensitivity of FDG-PET/CT for regional lymph nodes was higher in patients with larger primary tumors. The positivity of lymph-node metastasis for FDG-PET/CT was affected by carcinoembryonic antigen levels, tumor location, and cancer stage for regional lymph nodes and by age and cancer stage for distant lymph nodes (P < 0.05).

Conclusion

The sensitivity of FDG-PET/CT for regional lymph-node metastasis was not superior to that of CT. However, FDG-PET/CT provides helpful information for determining surgical plan especially in high risk patients group.

Citations

Citations to this article as recorded by

Evaluation of colon cancer prognostic factors by CT and MRI: an up-to-date review
Ruggeri B. Guimarães, Eduardo O. Pacheco, Serli N. Ueda, Dario A. Tiferes, Fernanda L. Mazzucato, Aley Talans, Ulysses S. Torres, Giuseppe D’Ippolito
Abdominal Radiology.2024; 49(11): 4003. CrossRef
Tomographie par émission de positons en cancérologie digestive
C. Aveline, F. Montravers
EMC - Radiologie et imagerie médicale - Abdominale - Digestive.2024; 42(1): 1. CrossRef
Can Cross-Sectional Imaging Reliably Determine Pathological Staging of Right-Sided Colon Cancers and Select Patients for More Radical Surgery or Neo-Adjuvant Treatment?
Florence Shekleton, Edward Courtney, Adrian Andreou, John Bunni
Cureus.2022;[Epub] CrossRef
Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging
Pier Paolo Mainenti, Arnaldo Stanzione, Salvatore Guarino, Valeria Romeo, Lorenzo Ugga, Federica Romano, Giovanni Storto, Simone Maurea, Arturo Brunetti
World Journal of Gastroenterology.2019; 25(35): 5233. CrossRef
Clinical evaluation of18F-fludeoxyglucose positron emission tomography/CT using point spread function reconstruction for nodal staging of colorectal cancer
Kazuya Kawashima, Kenichi Kato, Makiko Tomabechi, Mikaru Matsuo, Koki Otsuka, Kazuyuki Ishida, Ryuji Nakamura, Shigeru Ehara
The British Journal of Radiology.2016; 89(1063): 20150938. CrossRef
Short-term and oncologic outcomes of laparoscopic and open complete mesocolic excision and central ligation
Ik Yong Kim, Bo Ra Kim, Eun Hee Choi, Young Wan Kim
International Journal of Surgery.2016; 27: 151. CrossRef
Preoperative Staging With Positron Emission Tomography in Patients With Colorectal Cancer
Young Wan Kim, Ik Yong Kim
Annals of Coloproctology.2014; 30(6): 247. CrossRef

Clinical Characteristics of Colorectal Carcinoid Tumors: J Korean Soc Coloproctol. 2011;27(1):17-20. Published online February 28, 2011; DOI: https://doi.org/10.3393/jksc.2011.27.1.17

6,746 View
49 Download
20 Citations

Abstract PDF

Purpose

The carcinoid tumor was recently categorized as a malignant disease due to its possibility of metastasis. This study was aimed to investigate the clinical characteristics and the metastatic rate of colorectal carcinoid tumors.

Methods

Charts were reviewed for 502 patients diagnosed with and treated for colorectal carcinoid tumors between January 2006 and December 2009. The location, size, depth and metastatic status of the tumors were collected.

Results

Including 24 synchronous tumors from 12 patients, 514 carcinoid tumors were removed. Most of them were found in the rectum (97.3%). The male-to-female ratio was 1.38 to 1, and mean age was 50.2 ± 11.4 years. The mean tumor size was 5.8 ± 3.6 mm. Less than 10-mm-sized tumors had a 1.95% lymph node metastatic rate; tumors with sizes from 10 mm to 20 mm and larger than 20 mm had 23.5% and 50% lymph node metastatic rates, respectively. Two cases had distant metastasis; one with a 22-mm-sized tumor metastasized to the liver, and the other with a 20-mm-sized tumor metastasized to the peritoneum. Among 414 patients who completed metastatic studies, 93.8% were classified as stage I, 0.9% as stage II, 4.8% as stage III and 0.5% as stage IV.

Conclusion

Colorectal carcinoid tumors smaller than 10 mm have a low rate of lymph node metastasis, but those sized 10 mm or larger incur significant risk. Further investigation regarding additional risk factors should be done to develop proper treatment guidelines for these tumors.

Citations

Citations to this article as recorded by

Endoscopic treatment of rectal neuroendocrine tumors: a consecutive analysis of multi-institutional data
Jae Won Shin, Eun-Jung Lee, Sung Sil Park, Kyung Su Han, Chang Gyun Kim, Hee Chul Chang, Won Youn Kim, Eui Chul Jeong, Dong Hyun Choi
Annals of Coloproctology.2025; 41(3): 221. CrossRef
Clinical outcomes and risk factors associated with poor prognosis after endoscopic resection of 10–20 mm rectal neuroendocrine tumors: a multicenter, retrospective study of 10-year experience
Ja Jun Goo, Dong Hoon Baek, Hyung Wook Kim, Hong Sub Lee, Jong Yoon Lee, Su Bum Park, Geun Am Song, Sang Heon Lee, Jong Hoon Lee
Surgical Endoscopy.2023; 37(7): 5196. CrossRef
Stratification of rate of lymph node metastasis according to risk factors and oncologic outcomes in patients who underwent radical resection for rectal neuroendocrine tumors
Myung Jae Jin, Sung Sil Park, Dong-Eun Lee, Sung Chan Park, Dong Woon Lee, Kiho Yu, Hee Jin Chang, Chang Won Hong, Dae Kyung Sohn, Kyung Su Han, Bun Kim, Byung Chang Kim, Jae Hwan Oh
Annals of Coloproctology.2023; 39(6): 467. CrossRef
Risk factors of lymph node metastasis in rectal neuroendocrine tumors*
Donghong Liang, Zhennan Niu, Xiaofang Sun, Changjuan Meng, Zhuang Liu
Oncology and Translational Medicine.2022; 8(4): 186. CrossRef
Risk of lymph node metastasis after endoscopic treatment for rectal NETs 10 mm or less
Yutaka Inada, Naohisa Yoshida, Kohei Fukumoto, Ryohei Hirose, Ken Inoue, Osamu Dohi, Takaaki Murakami, Kiyoshi Ogiso, Akira Tomie, Munehiro Kugai, Hiroyuki Yoriki, Yoshikazu Inagaki, Daisuke Hasegawa, Kotaro Okuda, Takashi Okuda, Yukiko Morinaga, Mitsuo K
International Journal of Colorectal Disease.2021; 36(3): 559. CrossRef
Grade G2 Rectal Neuroendocrine Tumor Is Much More Invasive Compared With G1 Tumor
Yi-Wei Li, Yi-Ping He, Fang-Qi Liu, Jun-Jie Peng, San-Jun Cai, Ye Xu, Ming-He Wang
Frontiers in Oncology.2021;[Epub] CrossRef
Nodal metastases in small rectal neuroendocrine tumours
Sarah O’Neill, Amyn Haji, Suzanne Ryan, Dominique Clement, Konstantinos Sarras, Bu Hayee, Nicola Mulholland, John K. Ramage, Rajaventhan Srirajaskanthan
Colorectal Disease.2021; 23(12): 3173. CrossRef
Analysis of Risk Factors of Lymph Node Metastasis in Rectal Neuroendocrine Neoplasms Using Multicenter Data
Gengzhou Wei, Xingyu Feng, Wei Wang, Yu Zhang, Yujie Zeng, Minhu Chen, Ye Chen, Jie Chen, Zhiwei Zhou, Yong Li
Future Oncology.2018; 14(18): 1817. CrossRef
Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors
Beonghoon Sohn, Yoomin Kwon, Seung-Bum Ryoo, Inho Song, Yoon-Hye Kwon, Dong Woon Lee, Sang Hui Moon, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park
Journal of Gastrointestinal Surgery.2017; 21(12): 2066. CrossRef
The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution
Seung Tae Kim, Sang Yun Ha, Jeeyun Lee, Sung No Hong, Dong Kyung Chang, Young Ho Kim, Yoon Ah Park, Jung Wook Huh, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Hee Cheol Kim, Young Suk Park
Medicine.2016; 95(19): e3534. CrossRef
Comparison of Endoscopic Mucosal Resection With Circumferential Incision and Endoscopic Submucosal Dissection for Rectal Carcinoid Tumor
Ru Chen, Xiang Liu, Siyu Sun, Sheng Wang, Nan Ge, Guoxin Wang, Jintao Guo
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2016; 26(3): e56. CrossRef
Nonlinear optical microscopy for label-free detection of gastrointestinal neuroendocrine tumors
Lianhuang Li, Liwei Jiang, Zhifen Chen, Deyong Kang, Zhenrong Yang, Xing Liu, Weizhong Jiang, Shuangmu Zhuo, Guoxian Guan, Yongjian Zhou, Jianxin Chen
Lasers in Medical Science.2016; 31(7): 1285. CrossRef
Rektale neuroendokrine Tumoren: chirurgische Therapie
O. Radulova-Mauersberger, S. Stelzner, H. Witzigmannn
Der Chirurg.2016; 87(4): 292. CrossRef
Hindgut Neuroendocrine Neoplasia
James D. Smith, Govind Nandakumar
Indian Journal of Surgical Oncology.2016; 7(1): 73. CrossRef
Are Small Rectal Neuroendocrine Tumors Safe?
Jae Ho Choi, Jae Myung Cha
Intestinal Research.2015; 13(2): 103. CrossRef
Rectal carcinoids: a systematic review
Frank D. McDermott, Anna Heeney, Danielle Courtney, Helen Mohan, Des Winter
Surgical Endoscopy.2014; 28(7): 2020. CrossRef
Clinicopathological analysis of colorectal carcinoid tumors and patient outcomes
Hung-Hsin Lin, Jen-Kou Lin, Jeng-Kai Jiang, Chun-Chi Lin, Yuan-Tzu Lan, Shung-Haur Yang, Huann-Sheng Wang, Wei-Shone Chen, Tzu-Chen Lin, Wen-Yih Liang, Shih-Ching Chang
World Journal of Surgical Oncology.2014;[Epub] CrossRef
Endoscopic submucosal dissection for colorectal tumors—1,000 colorectal ESD cases: one specialized institute’s experiences
Eun-Jung Lee, Jae Bum Lee, Suk Hee Lee, Do Sun Kim, Doo Han Lee, Doo Seok Lee, Eui Gon Youk
Surgical Endoscopy.2013; 27(1): 31. CrossRef
Factors Associated with Lymph Node Metastasis in Radically Resected Rectal Carcinoids: a Systematic Review and Meta-analysis
Xin Zhou, Haiting Xie, Lingduo Xie, Jing Li, Wei Fu
Journal of Gastrointestinal Surgery.2013; 17(9): 1689. CrossRef
Variable Clinical Classifications and Diagnostic Coding Systems of Colorectal Neuroendocrine Tumor
Byung Chang Kim, Cheol Hee Park, Tae Il Kim, Suck-Ho Lee, Jin-Oh Kim, Hyun Soo Kim, Dong-Hoon Yang, Bora Keum, Sung Pil Hong, Seong-Eun Kim, Hyun Gun Kim, Jeong Eun Shin, Jae Myung Cha, Young Eun Joo, Dong Il Park, Hwang Choi, Kyu Chan Huh, Seung-Jae Myun
Intestinal Research.2013; 11(1): 14. CrossRef

Prognostic Analysis According to N Stage and Circumferential Resection Margin in Patients with Locally Advanced Rectal Cancer.: Sohn, Yong Ki , Shin, Jin Yong , Hong, Kwan Hee; J Korean Soc Coloproctol. 2010;26(3):217-224.; DOI: https://doi.org/10.3393/jksc.2010.26.3.217

2,012 View
10 Download

Abstract PDF: PURPOSE
Efforts must be made to clarify the contribution of lymph node metastasis (NM) to adjuvant (chemo) radiotherapy following a curative resection for rectal cancer as the circumferential resection margin (CRM) has increasingly become a more reliable prognosticator for rectal cancer. This study examined the prognostic impact of NM on local recurrence, disease-free survival. and overall survival rates in curatively resected patients with locally advanced rectal cancer.
METHODS
Two hundred two patients with locally advanced rectal cancer curatively resected in Pusan Paik Hospital from January 1995 to December 2003 were enrolled. These patients were divided into three groups according to lymph node (N) disease (N0: node negative, n=79; N1: 1-3 nodes positive, n=70; N2: > or =4 nodes positive, n=53). The potential prognostic factors, for example, T and N stage, preoperative carcinoembryonic antigen (CEA), postoperative (chemo) radiotherapy, operative methods, and several pathologic variables, were assessed among the three groups. The potential clinicopathologic factors were analyzed by using the Kaplan-Meier method, and the prognostic factors were compared in a Cox regression model. Also, we compared the oncologic results of 26 patients with a positive CRM (CMI) with those of the N1 and the N2 subgroups.
RESULTS
N2 patients had an impaired 5-yr local control rate (19.1%) compared with N0 (6.8%) and N1 (11.6%, P=0.029) patients after a median follow up of 60 months (range, 6 to 156 mo). Differences in disease-free and overall survival were also significantly different statistically among the three groups (84.0% and 85.2% for N0; 54.9% and 65.1% for N1; 37.3% and 49.8% for N2; P<0.001 both). The impact of NM on the local recurrence, disease-free survival and overall survival was confirmed in the regression model for the curatively resected patients. There were no significant differences in the recurrence and the survival rates between CMI and N2 stage.
CONCLUSION
NM has an independent prognostic impact on local failure and on disease-free survival and overall survival. Based on these findings, NM should be considered as an indicatior for adjuvant therapy. Although the prognostic impact of CMI is similar to that of N2, a larger prospective study is needed to clarify the prognostic association of CMI and N2.

IMA-origin Lymph Node Metastasis in Left Colon Cancer.: Lee, Jae Hoon , Jung, Sang Hun , Kim, Hyun Jin , Hwang, Jong Sung , Kim, Jae Hwang , Shim, Min Chul; J Korean Soc Coloproctol. 2008;24(5):380-385.; DOI: https://doi.org/10.3393/jksc.2008.24.5.380

2,670 View
17 Download

Abstract PDF: PURPOSE
Although an extended colon resection with high ligation of the inferior mesenteric artery (IMA) generally has been recommended as curative surgery for advanced left colon cancer (LCC), it shows little or no survival advantage over segmental resection with low ligation of IMA. The present study is to determine the risk factors associated with IMA-origin lymph-node (LN) metastasis and to clarify the implication of IMA-origin LN metastasis.
METHODS
We examined the clinicopathological results of 200 cases of LCC. LN dissection was performed as follows: D2 en-bloc resection of the primary tumor, IMA-origin LN dissection, and paraaortic LN dissection.
RESULTS
The incidence of IMA-origin LN metastasis of LCC was 4.5% (9 cases), and all cases involved sigmoid colon cancer. The independent risk factors of IMA-origin LN metastasis were four or more regional LN metastases (hazard ratio: 16.51, 95% confidence interval: 1.60~164.12) and a preoperative CEA level of greater than 6 ng/ml of (hazards ratio: 6.63, 95% confidence interval: 1.06~41.32). The incidence of IMA-origin LN metastasis among stage IIIC patients was 26.7%. Five of the 9 (55.6%) cases of IMA-origin LN metastasis had a concomitant paraaortic LN metastasis.
CONCLUSIONS
The incidence of IMA-origin LN metastasis among patients with LCC was low; however, IMA-origin LN metastasis should be considered as a systemic metastasis.

Clinical Significance of E-cadherin and beta-catenin Complex Expression in T2 Colorectal Cancer.: Kim, Jin Soo , Ko, Yong Taek , Hur, Hyuk , Min, Byung Soh , Kim, Nam Kyu , Sohn, Seung Kook , Cho, Chang Hwan , Ahn, Choong Bae , Kim, Hoguen; J Korean Soc Coloproctol. 2008;24(2):91-99.; DOI: https://doi.org/10.3393/jksc.2008.24.2.91

1,954 View
8 Download

Abstract PDF: PURPOSE
Expression of adhesion molecules is significantly correlated with the invasion and the metastasis of colorectal cancer. The aim of this study is to identify the importance of the expressions of E-cadherin and beta-catenin as a prognostic factor in T2 colorectal cancer. METHODS: Forty-five cases of primary T2 colorectal cancers were selected between February 1997 and February 2000. We evaluated the membranous expressions of E-cadherin and beta-catenin by using immunohistochemisty and analyzed the relationship with various clinicopathologic parameters.
RESULTS
Loss of membranous E-cadherin was significantly associated with histologic differentiation (P=0.023), vascular invasion (P<0.001), lymphatic invasion (P<0.001), and lymph-node metastases (P=0.001). Similar patterns were observed in the expression of beta-catenin. The correlation between the E-cadherin and the beta-catenin expressions was statistically significant (P<0.001). In the multivariate analysis, neither the loss of expression of E-cadherin nor beta-catenin is a risk factor affecting lymph-node metastasis in T2 colorectal cancers. However, there were significant differences in the 5-year disease-free survival rates between the positive (+/-, +) and the negative (-) expression groups of E-cadherin and beta-catenin (P=0.015, 0.03). CONCLUSIONS: This study suggests that loss of membranous expression of E-cadherin and beta-catenin molecules correlates with poor prognostic factors and indicates invasion and metastasis in T2 colorectal cancer, which, therefore, might be predictive of short survival in these patients.

Correlation of beta-catenin and p53 Protein Expression with Clinico-pathologic Characteristics of Colorectal Cancer.: Moon, Kil Min , Park, Young Jin , Kim, Han Seung , Park, Seung Hae , Kim, Ji Il , Kim, Ki Hong , Song, Byung Joo , Lee, Meung Soo , Kim, Chul Nam , Chang, Seok Hyo; J Korean Soc Coloproctol. 2002;18(5):311-316.

1,424 View
9 Download

Abstract PDF: PURPOSE
Both the beta-catenin and p53 play a crucial role in the process of colon carcinogenesis. The expression of beta-catenin and/or p53 has been reported to be associated with pathologic features of tumor and prognosis of patients. In addition, several recent studies have suggested a close biological association between p53 expression and nuclear beta-catenin level. We analyzed the pathologic variables and p53 expression according to the intra-nuclear beta-catenin expression in colon cancer to make such assumptions more clear since they are still controversial issues.
METHODS
The expressions of beta-catenin, p53 and Ki-67 protein in colon cancer were determined by immunohistochemical staining. The relationship between these protein expressions and tumor characteristics was statistically analyzed.
RESULTS
The intra-nuclear beta-catenin accumulation was not associated with any of the pathological variables including lymph node metastasis and tumor differentiation, but it was correlated with higher level of Ki-67 proliferation index (P=0.006) and negative staining of p53 (P=0.015). Positive p53 staining was significantly associated with lymph node metastasis (P=0.006), lymphatic invasion (P=0.03) and venous invasion (P=0.02).
CONCLUSION
These results support the suggestion that intra-nuclear accumulation of beta-catenin may regulate the p53 activity in colorectal cancer. In addition, positive staining of p53 may be used as a valuable prognostic indicator since it was strongly associated with lymph node metastasis, lymphatic and venous invasion.

The Risk Factors of Lymph Node Metastasis in Submucosal Invasive Colorectal Cancer.: Choi, Pyong Wha , Yu, Chang Sik , Jang, Se Jin , Kim, Mi Jung , Han, Kyong Rok , Jung, Sang Hun , Yoon, Yong Sik , Kim, Hee Cheol , Kim, Jin Cheon; J Korean Soc Coloproctol. 2006;22(4):264-270.

2,238 View
43 Download

Abstract PDF: PURPOSE
Recent studies have shown a 7~15% lymph node (LN) metastasis rate in submucosal invasive colorectal cancer (SICC). Identification of risk factors for LN metastasis is crucial in the choice of therapeutic modalities for SICC. The present study was performed to assess the possibility of LN metastasis and to determine the risk factors of LN metastasis in SICC.
METHODS
A retrospective study of 168 patients with SICC who underwent a curative resection between June 1989 and December 2004 at Asan Medical Center was conducted. The level of submucosal invasion was classified into upper third (sm1), middle third (sm2), and lower third (sm3) according to the submucosal depth of invasion. The following carcinoma-related variables were assessed: tumor size, tumor location, level of submucosal invasion, cell differentiation, lymphovascular invasion, neural invasion, and tumor cell dissociation (TCD).
RESULTS
The overall LN metastasis rate was 14.3%. According to the level of submucosal invasion, LN metastasis was seen as follows: sm1, n=4 (4.2%), sm2, n= 10 (21.3%), and sm3, n=10 (38.5%) (P=0.039). According to cell differentiation, LN metastasis was observed as follows: well-differentiated, n=4 (4.9%), moderately differentiated, n=19 (22.9%), and poorly differentiated, n=1 (25.0%) (P=0.028). Nineteen of the 66 cases (28.8%) with TCD had significantly higher risk of LN metastasis as did 5 of the 102 cases (4.9%) without TCD (P=0.045). No statistical difference was observed in the risk of LN metastasis with regard to tumor location, tumor size, neural invasion, or lymphovascular invasion.
CONCLUSIONS
Submucosal invasion, cell differentiation, and tumor cell dissociation were significant pathologic predictors of LN metastasis in SICC. As SICC has considerable risk of LN metastasis, local excision should be reserved to highly selective sm1 cancers.

Prevalence of Liver Metastasis of Colorectal Cancer According to Clinical and Histopathologic Characteristics.: Ryu, Dong Won , Lee, Seung Hyun , Ahn, Byung Kwon , Baek, Sung Uhn; J Korean Soc Coloproctol. 2002;18(4):246-250.

1,554 View
4 Download

Abstract PDF: PURPOSE
In Korea, the incidence of colorectal cancer is increasing quickly. The liver metastasis is the most common cause of death. But current diagnosis methods such as CT, MRI, USG have significant false negative rate (up to 15%) especially in micrometastasis. We designed this study to identify the predictive value of liver metastasis of known clinical and histopathologic factors.
METHODS
Retrospectively, we reviewed 248 patients who underwent resection of colorectal cancer between 1997 and 1999. Clinical and histopathologic factors of colorectal cancer with synchronous liver metastasis was compared with those without liver metastasis.
RESULTS
Twenty-nine patients had synchronous liver metastasis. In clinical factors, there was significant difference in liver metastatic rate according to tumors location, and serum carcinoembryonic antigen (CEA). The metastatic rate of right colon was 9.5%, left colon was 27.9%, rectum was 8.0% (P=0.001). The metastatic rate in cases with CEA<5.0 ng/ml was 4.3%, CEA> or =5.0 ng/ml was 18.4% (P=0.001). In histopathologic factors, there was significant difference in liver metastatic rate according to depth of tumor invasion (T-stage), extent of lymph node metastasis (N-stage), venous invasion (9.5 vs 19.3 %, P=0.043), perineural invasion (8.5 vs 19.7 %, P=0.013). The metastatic rate of T1 was 0%, T2 was 3.43%, T3 was 12.3%, T4 was 26.9% (P=0.009). The metastatic rate of N0 was 4.9%, N1 was 15.6%, N2 was 30.3% (P=0.002). But there was no significant difference according to tumor size, histologic differentiation grade, lymphatic invasion. In multi- variant analysis with significant factors, independent factor associated with liver metastasis was N-stage.
CONCLUSIONS
In colorectal cancer, tumor location, CEA, T-stage, N-stage, venous invasion, and perineural invasion of tumor cell had significant relationship with liver metastasis. The most important factor associated with liver metastasis was N-stage. This factors shoud be considered carefully in the planning treatment and follow up in colorectal cancer.

Predicting Lymph Node Metastasis in Patients with Advanced Rectal Cancer: A Prospective Study for the Characteristics of Lymph Node Metastasis of Mesorectum and Extra-Mesorectum.: Shim, Kang Sup , Kim, Kwang Ho , Yoon, Dae Kun , Kim, Ki Hyun , Kim, Sung Phill , Lee, Kun Young , Choi, Eun Chang , Sung, Sun Hee , Han, Woon Sup , Pa, Eung Bum; J Korean Soc Coloproctol. 1998;14(3):399-412.

1,680 View
29 Download

Abstract PDF: It is very important to tallow that pelvic lymphadenectomy associated with proctectomy must be based on the principle of oncologic surgery and encompass all predictable pathways of extension of rectal cancer for curative surgical resection. We investigated the characteristis of lymph node metastasis in patients with rectal cancer prospectively. 108 consecutive patients with rectal cancer underwent curative surgical resection were enrolled in this study. Rectal cancers were divided into two groups, upper and mid-lower. Upper rectal cancer was defined as the tumor above the peritoneal reflexion. Lymph nodes were stratified as mesorectum, distal mesorectum (defined as distal part more than 2 cm from the lower margin of the tumor), intemal iliac, common iliac, presacral, superior rectal artery, inferior mesenteric artery, paraaortic lymph node. Average number of sampled nodes in these groups 18.5+/-10.7, 3.6+/-3, 2.3+/-3, 1.8+/-1.3, 4 +/-4.1, 1.6+/-2, 3.1+/-3.2, 5.4+/-4.7 respectively. 60 of all patients showed positive lymph node. The over all percentages of patients with positive lymph node was 53% in mesorectum, 12% in distal mesorectum, 8% in intemal iliac, 4.5% in common iliac, 4.5% in presacral, 10% in superior rectal artery, 6.5% in inferior mesenteric artery, 4% in paraaortic lymph node. The over all percentages of patients with positive lymph nodes in each group were 60% (27/45), 9% (4/45), 6.5% (3/45),2% (1/45), 2% (1/45), 13% (6/45), 11% (5/45), 1% (1/45) respectively in upper rectal cancer, 49% (31/63), 14% (9/63), 9.5% (6/63), 6% (4/63), 6% (4/63), 8% (5/63),3% (2/63),5% (3/63) respectively in mid-lower rectal cancer. There were skip metastasis in 3 patients with upper rectal cancer, 2 patients with mid-lower rectal cancer. Age, depth of invasion, tumor size, tumor differentiation among clinicopathologic factors were predictive factors of lymph node metastasis to mesorectum. Risk factors of metastasis to extra-mesorectal lymph node were younger age (<40), poorly differentiation, larger tumor size (>5.0 cm), involved circimferential (>50%), and positive CA 19-9 (>37 U/ml). These results suggest that more careful upward lymphadenectomy must be carried out especially in upper rectal cancer and also careful lateral dissection in selected patients and more generous excision of distal mesorectum especially in mid-lower rectal cancer is needed for curative resection according to clinicopathologic factors.

Pattern of Recurrences and Metastases according to Regional Lymph Node Metastasis of Colorectal Cancer.: Park, In Ja , Kim, Hee Cheol , Yu, Chang Sik , Kim, Jin Cheon; J Korean Soc Coloproctol. 2006;22(1):47-53.

1,315 View
7 Download

Abstract PDF: PURPOSE
We aimed to verify the pattern of recurrences or metastases of primary colorectal cancer according to regional lymph node metastasis and to use it for follow up.
METHODS
A study was undertaken of 537 stage II and III patients who had undergone a resection of colorectal cancer between July 1989 and December 2002 and who had been identified as having a recurrence during follow up and of 439 stage IV patients who had undergone a resection of the primary tumor during the same period and who could be evaluated for regional lymph node status. Patients were classified into two groups according to regional lymph node status: no lymph node metastasis (214) and lymph node metastasis (762). Univariate and multivariate (Cox's model) analyses of recurrence were employed to identify differences. Statistical significance was assigned to a P value of <0.05.
RESULTS
In the lymph-node-metastasis group, female, poorly differentiated, and infiltrating type cancer were dominant. The patterns of recurrence were hematogenous in 729 cases (74.7%), local recurrence in 101 cases (10.3%), peritoneal seeding in 107 cases (11.0%), and lymph node recurrence in 116 cases (11.9%). Hematogenous metastasis was the most common type of metastasis or recurrence in both groups. Compared with the no-lymph-node-metastasis group, the rates of lymph node recurrence (P<0.01) and local recurrence (P=0.02) were much higher in the were more frequent lymph-node-metastasis group. Local recurrence was frequent in rectal cancer, and the location of the primary tumor greatly influenced on local recurrence. Therefore, lymph node recurrence was strongly influenced by regional lymph node metastasis.
CONCLUSIONS
The pattern of recurrence differed according to the characteristics of the primary tumor. Especially, in the lymph-node-metastasis group, lymph node and local recurrences were more common than they were in the no-lymph-node-metastasis group. Therefore, lymph node metastasis should be considered for follow up.

Impact of the Number of Nodes Examined on the Prognosis of Dukes B Colorectal Cancer.: Oh, Soo Youn , Lee, Suk Hwan , Ku, Hae Soo , Kim, Kwang Ho , Park, Eung Bum; J Korean Soc Coloproctol. 2003;19(3):157-164.

1,595 View
18 Download

Abstract PDF: PURPOSE
Metastasis to the regional lymph nodes is the most important prognostic indicator in patients with colorectal cancer (CRC). The number of lymph nodes examined for adequate staging is still controversial. The aim of this study was to determine if the number of lymph nodes after curative surgery is associated with long-term outcome in patents with Dukes B CRC.
METHODS
A retrospective analysis was performed in 174 consecutive patients with Dukes B CRC who underwent curative resection from 1990 to 1999. Patients were stratified according to the number of nodes examined as group A (less than 12 nodes) and group B (12 or more nodes). End-points were local and systemic recurrence and relapse-free survival. Comparisons between the groups were performed by Kaplan-Meier methods and chi-square test as appropriate.
RESULTS
There were 115 men (66%). The mean number of nodes examined was 13.4 with the median of 11. No significant difference was found in the number of nodes examined between colon and rectum (16+/-10.6 vs. 13+/-10.0, P=0.675). However, the number of lymph nodes examined tends to be more in recent period of study and if the specimens were examined in the fresh status. With the median follow-up of 44 months, there were 5 local recurrences (2.9%), 22 systemic recurrences (12.6%), and 2 combined local and systemic recurrences (1.1%). Most of the recurrences were observed in group A (79%). The difference of 5-year relapse-free survival rates between the groups was also statistically significant (group A: 73.5%, group B: 91.7%, log-rank test, P=0.0114). The pT stage and number of lymph nodes examined were the independent variables associated with relapse-free survival in multivariate analysis.
CONCLUSIONS
The number of lymph nodes examined has prognostic value in patients undergoing curative resection for CRC. Based on our analysis, we recommended at least 12 lymph nodes should be analyzed for accurate staging of CRC.

First
Prev
Page of 1
Next
Last

Search